Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Presentation Operator Good afternoon, and thank you for holding. Welcome to the Motorola Solutions 4th-Quarter 2024 Earnings ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果